Document:

Pledge and Security Agreement

 Exhibit 4.7 
 EXECUTION COPY 
 PLEDGE AND SECURITY AGREEMENT 

dated as of November 17, 2010 
 between 
 EACH OF THE GRANTORS PARTY HERETO 

and 

U.S. HEALTHCARE I, L.L.C., 
 as Collateral Agent 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	PAGE	 
	SECTION 1. DEFINITIONS; GRANT OF SECURITY	  	 	1	  
	 1.1
	  	General Definitions	  	 	1	  
	 1.2
	  	Definitions; Interpretation	  	 	7	  
		
	SECTION 2. GRANT OF SECURITY	  	 	7	  
	 2.1
	  	Grant of Security	  	 	7	  
	 2.2
	  	Certain Limited Exclusions	  	 	9	  
		
	SECTION 3. SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE	  	 	10	  
	 3.1
	  	Security for Obligations	  	 	10	  
	 3.2
	  	Continuing Liability Under Collateral	  	 	10	  
		
	SECTION 4. CERTAIN PERFECTION REQUIREMENTS	  	 	10	  
	 4.1
	  	Delivery Requirements	  	 	10	  
	 4.2
	  	Control Requirements	  	 	10	  
	 4.3
	  	Intellectual Property Recording Requirements	  	 	11	  
	 4.4
	  	Other Actions	  	 	12	  
		
	SECTION 5. REPRESENTATIONS AND WARRANTIES	  	 	13	  
	 5.1
	  	Grantor Information & Status	  	 	13	  
	 5.2
	  	Collateral Identification, Special Collateral	  	 	13	  
	 5.3
	  	Ownership of Collateral and Absence of Other Liens	  	 	14	  
	 5.4
	  	Status of Security Interest	  	 	14	  
	 5.5
	  	Goods & Receivables	  	 	15	  
	 5.6
	  	Pledged Equity Interests, Investment Related Property	  	 	16	  
	 5.7
	  	Intellectual Property	  	 	16	  
	 5.8
	  	Secured Obligations	  	 	17	  
	 5.9
	  	Miscellaneous	  	 	17	  
		
	SECTION 6. COVENANTS AND AGREEMENTS	  	 	17	  
	 6.1
	  	Grantor Information and Status	  	 	17	  
	 6.2
	  	Collateral Identification; Special Collateral	  	 	18	  
	 6.3
	  	Ownership of Collateral and Absence of Other Liens	  	 	18	  
	 6.4
	  	Status of Security Interest	  	 	18	  
	 6.5
	  	Goods and Receivables	  	 	18	  
	 6.6
	  	Pledged Equity Interests, Investment Related Property	  	 	20	  
	 6.7
	  	Intellectual Property	  	 	21	  
		
	SECTION 7. FURTHER ASSURANCES; ADDITIONAL GRANTORS	  	 	23	  
	 7.1
	  	Further Assurances	  	 	23	  
	 7.2
	  	Additional Grantors	  	 	24	  
		
	SECTION 8. COLLATERAL AGENT APPOINTED ATTORNEY-IN-FACT	  	 	24	  
	 8.1
	  	Power of Attorney	  	 	24	  
	 8.2
	  	No Duty on the Part of Collateral Agent or Secured Parties	  	 	25	  
	 8.3
	  	Appointment Pursuant to Credit Agreement	  	 	25	  

  
 i 

  

							
	SECTION 9. REMEDIES	  	 	26	  
	 9.1
	  	Generally	  	 	26	  
	 9.2
	  	Application of Proceeds	  	 	27	  
	 9.3
	  	Sales on Credit	  	 	27	  
	 9.4
	  	Investment Related Property	  	 	28	  
	 9.5
	  	Intellectual Property License and NDA and ANDA Escrow Agreement	  	 	28	  
	 9.6
	  	Intellectual Property	  	 	29	  
	 9.7
	  	Cash Proceeds; Deposit Account and Controlled Accounts	  	 	30	  
		
	SECTION 10. COLLATERAL AGENT	  	 	31	  
		
	SECTION 11. CONTINUING SECURITY INTEREST; TRANSFER OF LOANS	  	 	31	  
		
	SECTION 12. STANDARD OF CARE; COLLATERAL AGENT MAY PERFORM	  	 	31	  
		
	SECTION 13. MISCELLANEOUS	  	 	32	  
		
	SECTION 14. CONFLICTS	  	 	32	  

 SCHEDULE 5.1 — GENERAL
INFORMATION 
 SCHEDULE 5.2 — COLLATERAL IDENTIFICATION 
 SCHEDULE 5.4 — FINANCING STATEMENTS 
 SCHEDULE 5.5 — LOCATION OF EQUIPMENT AND INVENTORY

 SCHEDULE 5.7 — INTELLECTUAL PROPERTY – NON-INFRINGEMENT 
 EXHIBIT A — PLEDGE SUPPLEMENT 
 EXHIBIT B — SECURITIES ACCOUNT CONTROL AGREEMENT

 EXHIBIT C — DEPOSIT ACCOUNT CONTROL AGREEMENT 
 EXHIBIT D — UNCERTIFICATED SECURITIES CONTROL AGREEMENT 
 EXHIBIT E — PATENT SECURITY
AGREEMENT 
 EXHIBIT F — TRADEMARK SECURITY AGREEMENT 
 EXHIBIT G — COPYRIGHT SECURITY AGREEMENT 

  
 ii 

 This PLEDGE AND SECURITY AGREEMENT, dated as of November 17, 2010 (as it may be
amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), among K-V PHARMACEUTICAL COMPANY, a Delaware corporation (“Borrower”), certain Subsidiaries of Borrower party hereto
from time to time, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (together with Borrower, each, a “Grantor,” and collectively, the “Grantors”), and U.S. HEALTHCARE I,
L.L.C. (“Healthcare I”), as collateral agent for the Secured Parties (as herein defined) (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”).

 RECITALS: 
 WHEREAS, capitalized terms used in these Recitals shall have the respective meanings set forth for such terms in Section 1.1 hereof; 

WHEREAS, reference is made to that certain Credit and Guaranty Agreement, dated as of the date hereof (as it may be amended,
restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among Borrower, certain Subsidiaries of Borrower, as Guarantors, the Lenders party thereto from time to time (the
“Lenders”) and Healthcare I, as Administrative Agent (together with its successors and permitted assigns in such capacity, “Administrative Agent”) and Collateral Agent; 

WHEREAS, in consideration of the extensions of credit and other accommodations of the Lenders as set forth in the Credit
Agreement, each Grantor has agreed to secure such Grantor’s Obligations under the Credit Documents; 
 WHEREAS, the
parties hereto desire to more fully set forth their respective rights in connection with such security interest as set forth herein; and 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein contained, and for other good and valuable consideration the receipt and sufficiency of which is
hereby acknowledged, each Grantor and the Collateral Agent agree as follows: 
 SECTION 1. DEFINITIONS; GRANT OF SECURITY. 

1.1 General Definitions. In this Agreement, the following terms shall have the following meanings: 

“Account” shall mean any “account” as such term is defined in the UCC, and in any event shall
include but shall not be limited to, all rights to payment of any monetary obligation, whether or not earned by performance, (i) for property that has been or is to be sold, leased, licensed, assigned or otherwise disposed of, (ii) for
services rendered or to be rendered, (iii) for a policy of insurance issued or to be issued, (iv) for a secondary obligation incurred or to be incurred, (v) for energy provided or to be provided, (vi) for the use or hire of a
vessel under a charter or other contract, (vii) arising out of the use of a credit or charge card or information contained on or for use with the card, (viii) as winnings in a lottery or other game of chance operated or sponsored by a
State, governmental unit of a State, or person licensed or authorized to operate the game by a State or governmental unit of a State or (ix) for tax refunds. Without limiting the foregoing, the term “account” shall include all
Health-Care-Insurance Receivables. 
 “Additional Grantors” shall have the meaning assigned in
Section 7.2. 

  
 1 

 “Agreement” shall have the meaning set forth in the
preamble. 
 “Borrower” shall have the meaning set forth in the preamble. 

“Cash Proceeds” shall have the meaning assigned in Section 9.7. 

“Chattel Paper” shall mean “chattel paper” as such term is defined in the UCC Without limiting
the foregoing, the term “Chattel Paper” shall in any event include all Tangible Chattel Paper and all Electronic Chattel Paper. 
 “Collateral” shall have the meaning assigned in Section 2.1. 
 “Collateral Account” shall mean any account established by the Collateral Agent. 
 “Collateral Agent” shall have the meaning set forth in the preamble. 
 “Collateral Records” shall mean books, records, ledger cards, files, correspondence, customer lists, supplier lists, blueprints, technical specifications, manuals, computer software and
related documentation, computer printouts, tapes, disks and other electronic storage media and related data processing software and similar items that at any time evidence or contain information relating to any of the Collateral or are otherwise
necessary or helpful in the collection thereof or realization thereupon. 
 “Collateral Support”
shall mean all property (real or personal) assigned, hypothecated or otherwise securing any Collateral and shall include any security agreement or other agreement granting a Lien or security interest in such real or personal property. 

“Contracts” shall mean (i) all contracts, agreements, licenses and covenants between any Grantor and
one or more additional parties (including but not limited to purchase orders) and (ii) any NDA and ANDA. 

“Contract Rights” shall mean all rights of any Grantor under each Contract, including, without
limitation, (i) any and all rights to receive and demand payments under any or all Contracts, (ii) any and all rights to receive and compel performance under any or all Contracts and (iii) any and all other rights, interests and
claims now existing or in the future arising in connection with any or all Contracts. 
 “Control”
shall mean: (1) with respect to any Deposit Accounts, control within the meaning of Section 9-104 of the UCC, (2) with respect to any Securities Accounts, Security Entitlements, Commodity Contract or Commodity Account, control within
the meaning of Section 9-106 of the UCC, (3) with respect to any Uncertificated Securities, control within the meaning of Section 8-106(c) of the UCC, (4) with respect to any Certificated Security, control within the meaning of
Section 8-106(a) or (b) of the UCC, (5) with respect to any Electronic Chattel Paper, control within the meaning of Section 9-105 of the UCC, (6) with respect to Letter of Credit Rights, control within the meaning of
Section 9-107 of the UCC and (7) with respect to any “transferable record”(as that term is defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform
Electronic Transactions Act as in effect in any relevant jurisdiction), control within the meaning of Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic
Transactions Act as in effect in the jurisdiction relevant to such transferable record. 
 “Controlled
Foreign Corporation” has the meaning set forth in Section 2.2. 

  
 2 

 “Copyright Licenses” shall mean any and all Contracts
providing for the granting of any right in or to any Copyright or otherwise providing for a covenant not to sue for infringement or other violation of any Copyright (whether such Grantor is licensee or licensor thereunder), including, without
limitation, the agreements required to be set forth on Schedule 5.2(II) under the heading “Copyright Licenses” (as such schedule may be amended or supplemented from time to time). 

“Copyrights” shall mean all United States, and foreign copyrights (whether or not the underlying works of
authorship have been published), including but not limited to copyrights in software and all rights in and to databases, all designs (including but not limited to industrial designs, Protected Designs within the meaning of 17 U.S.C. 1301 et. Seq.
and Community designs), and all Mask Works (as defined under 17 U.S.C. 901 of the U.S. Copyright Act), whether registered or unregistered, as well as all reversionary interests, and termination rights, and, with respect to any and all of the
foregoing: (i) all registrations and applications therefor including, without limitation, the registrations and applications required to be listed in Schedule 5.2(II) under the heading “Copyrights” (as such schedule may be amended or
supplemented from time to time), (ii) all extensions and renewals thereof, and (iii) all other rights of any kind accruing thereunder throughout the world. 

“Credit Agreement” shall have the meaning set forth in the recitals. 

“Domain Names” shall mean all internet domain names and associated URL addresses in or to which any
Grantor now or hereafter has any right, title or interest. 
 “Equipment” shall mean any
“equipment” as such term is defined in the UCC, and in any event, shall include, but shall not be limited to, all machinery, equipment, furnishings, fixtures and vehicles now or hereafter owned by any Grantor and any and all additions,
substitutions and replacements of any of the foregoing and all accessions thereto, wherever located, together with all attachments, components, parts, equipment and accessories installed thereon or affixed thereto. 

“Excluded Asset” shall mean any asset of any Grantor excluded from the security interest hereunder by
virtue of Section 2.2 hereof but only to the extent, and for so long as, so excluded thereunder. 

“Grantor” and “Grantors” shall have the meaning set forth in the preamble.

 “Insurance” shall mean (i) all insurance policies covering any or all of the Collateral
(regardless of whether the Collateral Agent is the loss payee thereof), (ii) any key man life insurance policies and (iii) all director and officer insurance policies providing coverage for claims made against a Grantor. 

“Intellectual Property” shall mean, the collective reference to all rights relating to intellectual
property, whether arising under the United States, multinational or foreign laws or otherwise, including without limitation, Copyrights, Patents, Domain Names, Trademarks, Trade Secrets, and all rights under Copyright Licenses, Patent Licenses,
Trademark Licenses and Trade Secret Licenses, and the right to sue or otherwise recover for any past, present and future infringement, dilution, misappropriation, or other violation or impairment thereof, including the right to receive all Proceeds
therefrom, including without limitation license fees, royalties, income, payments, claims, damages and proceeds of suit, now or hereafter due and/or payable with respect thereto. 

“Intellectual Property Security Agreement” shall mean each intellectual property security agreement
executed and delivered by the applicable Grantors, substantially in the form set forth in Exhibit E, Exhibit F and Exhibit G, as applicable. 

  
 3 

 “Inventory” shall mean merchandise, inventory and goods,
and all additions, substitutions and replacements thereof and all accessions thereto, wherever located, together with all goods, supplies, incidentals, packaging materials, labels, materials and any other items used or usable in manufacturing,
processing, packaging or shipping same, in all stages of production from raw materials through work in process to finished goods, and all products and proceeds of whatever sort and wherever located any portion thereof which may be returned,
rejected, reclaimed or repossessed by the Collateral Agent from any Grantor’s customers, and shall specifically include all “inventory” as such term is defined in the UCC 

“Investment Accounts” shall mean the Collateral Accounts, Securities Accounts, Commodity Accounts and
Deposit Accounts. 
 “Investment Related Property” shall mean: (i) all “investment
property” (as such term is defined in Article 9 of the UCC) and (ii) all of the following (regardless of whether classified as investment property under the UCC): all Pledged Equity Interests, Pledged Debt, the Investment Accounts and
certificates of deposit. 
 “IP License” shall mean the Intellectual Property License Agreement,
dated as of the date hereof, between Borrower and the Collateral Agent. 
 “Lender” and
“Lenders” shall have the meaning set forth in the recitals. 
 “Material Intellectual
Property” shall mean any Intellectual Property included in the Collateral that any Grantor has determined in its reasonable business judgment is material to the business of any Grantor. 

“NDA and ANDA Escrow Agreement” shall mean the Escrow Agreement, dated as of the date hereof, between
Borrower, the Collateral Agent and Wilmington Trust Company. 
 “Patent Licenses” shall mean all
Contracts providing for the granting of any right in or to any Patent or otherwise providing for a covenant not to sue for infringement or other violation of any Patent (whether such Grantor is licensee or licensor thereunder), including, without
limitation, the agreements required to be set forth on Schedule 5.2(II) under the heading “Patent Licenses” (as such schedule may be amended or supplemented from time to time). 

“Patents” shall mean all United States and foreign patents and certificates of invention, or similar
industrial property rights, and applications for any of the foregoing, including, without limitation: (i) each patent and patent application required to be listed in Schedule 5.2(II) under the heading “Patents” (as such schedule may
be amended or supplemented from time to time), (ii) all reissues, divisionals, continuations, continuations-in-part, extensions, renewals, and reexaminations thereof, and (iii) all other rights of any kind accruing thereunder throughout
the world. 
 “Permits” shall mean, to the extent permitted to be assigned by the terms thereof
or by applicable law, all licenses, permits, rights, orders, variances, franchises or authorizations of or from any governmental authority or agency (including but not limited to, all ANDAs and NDAs approved by the FDA). 

“Pledge Supplement” shall mean any supplement to this Agreement in substantially the form of Exhibit A.

  
 4 

 “Pledged Debt” shall mean all indebtedness for borrowed
money owed to such Grantor, whether or not evidenced by any Instrument, including, without limitation, all indebtedness described on Schedule 5.2(I) under the heading “Pledged Debt” (as such schedule may be amended or supplemented from
time to time), issued by the obligors named therein, the instruments, if any, evidencing any of the foregoing, and all interest, cash, instruments and other property or proceeds from time to time received, receivable or otherwise distributed in
respect of or in exchange for any or all of the foregoing. 
 “Pledged Equity Interests” shall
mean all Pledged Stock, Pledged LLC Interests, Pledged Partnership Interests and any other participation or interests in any equity or profits of any business entity including, without limitation, any trust and all management rights relating to any
entity whose equity interests are included as Pledged Equity Interests. 
 “Pledged LLC
Interests” shall mean all interests in any limited liability company (except MECW, LLC) and each series thereof including, without limitation, all limited liability company interests listed on Schedule 5.2(I) under the heading “Pledged
LLC Interests” (as such schedule may be amended or supplemented from time to time) and the certificates, if any, representing such limited liability company interests and any interest of such Grantor on the books and records of such limited
liability company or on the books and records of any securities intermediary pertaining to such interest and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time
received, receivable or otherwise distributed in respect of or in exchange for any or all of such limited liability company interests and all rights as a member of the related limited liability company. 

“Pledged Partnership Interests” shall mean all interests in any general partnership, limited partnership,
limited liability partnership or other partnership including, without limitation, all partnership interests listed on Schedule 5.2(I) under the heading “Pledged Partnership Interests” (as such schedule may be amended or supplemented from
time to time) and the certificates, if any, representing such partnership interests and any interest of such Grantor on the books and records of such partnership or on the books and records of any securities intermediary pertaining to such interest
and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such partnership
interests and all rights as a partner of the related partnership. 
 “Pledged Stock” shall mean
all shares of capital stock owned by such Grantor, including, without limitation, all shares of capital stock described on Schedule 5.2(I) under the heading “Pledged Stock” (as such schedule may be amended or supplemented from time to
time), and the certificates, if any, representing such shares and any interest of such Grantor in the entries on the books of the issuer of such shares or on the books of any securities intermediary pertaining to such shares, and all dividends,
distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such shares. 

“Receivables” shall mean all rights to payment, whether or not earned by performance, for goods or other
property sold, leased, licensed, assigned or otherwise disposed of, or services rendered or to be rendered, including, without limitation all such rights constituting or evidenced by any Account, Chattel Paper, Instrument, General Intangible,
Investment Related Property or Letter of Credit Rights, together with all of Grantor’s rights, if any, in any goods or other property giving rise to such right to payment and all Collateral Support and Supporting Obligations related thereto and
all Receivables Records. 

  
 5 

 “Receivables Records” shall mean (i) all original
copies of all documents, instruments or other writings or electronic records or other Records evidencing the Receivables, (ii) all books, correspondence, credit or other files, Records, ledger sheets or cards, invoices, and other papers
relating to Receivables, including, without limitation, all tapes, cards, computer tapes, computer discs, computer runs, record keeping systems and other papers and documents relating to the Receivables, whether in the possession or under the
control of Grantor or any computer bureau or agent from time to time acting for Grantor or otherwise, (iii) all evidences of the filing of financing statements and the registration of other instruments in connection therewith, and amendments,
supplements or other modifications thereto, notices to other creditors, secured parties or agents thereof, and certificates, acknowledgments, or other writings, including, without limitation, Lien search reports, from filing or other registration
officers, (iv) all credit information, reports and memoranda relating thereto and (v) all other written or non-written forms of information related in any way to the foregoing or any Receivable. 

“Secured Obligations” shall have the meaning assigned in Section 3.1. 

“Secured Parties” shall mean the Agents and Lenders. 

“Securities” shall mean any stock, shares, partnership interests, voting trust certificates, certificates
of interest or participation in any profit-sharing agreement or arrangement, options, warrants, bonds, debentures, notes, or other evidences of indebtedness, secured or unsecured, convertible, subordinated or otherwise, or in general any instruments
commonly known as “securities” or any certificates of interest, shares or participations in temporary or interim certificates for the purchase or acquisition of, or any right to subscribe to, purchase or acquire, any of the foregoing.

 “Specified Intellectual Property” shall mean (i) all issued Patents owned by any Grantor
(except to the extent indicated in Schedule 5.2(II) attached hereto under the heading “Patents” as intended to be abandoned or allowed to lapse); and (ii) all Trademark registrations and applications owned by any Grantor covering the
names of such Grantor’s products (except to the extent indicated in Schedule 5.2(II) attached hereto under the heading “Trademarks” as intended to abandoned or allowed to lapse or to not be renewed, or to the extent that any such
Trademark registration or application subsists in a jurisdiction where such products are no longer sold or marketed). 
 “Trademark Licenses” shall mean any and all Contracts providing for the granting of any right in or to any Trademark or otherwise providing for a covenant not to sue for infringement,
dilution or other violation of any Trademark or permitting co-existence with respect to a Trademark (whether such Grantor is licensee or licensor thereunder) , including, without limitation, the agreements required to be set forth on Schedule
5.2(II) under the heading “Trademark Licenses” (as such schedule may be amended or supplemented from time to time). 
 “Trademarks” shall mean all United States, and foreign trademarks, trade names, trade dress, corporate names, company names, business names, fictitious business names, service marks,
certification marks, collective marks, logos, other source or business identifiers and designs, whether or not registered, and with respect to any and all of the foregoing: (i) all registrations and applications therefor including, without
limitation, the registrations and applications required to be listed in Schedule 5.2(II) under the heading “Trademarks”(as such schedule may be amended or supplemented from time to time), (ii) all extensions or renewals of any of the
foregoing, (iii) all of the goodwill of the business connected with the use of and symbolized by any of the foregoing, and (iv) all other rights of any kind accruing thereunder throughout the world. 

“Trade Secret Licenses” shall mean any and all Contracts providing for the granting of any right in or to
Trade Secrets (whether such Grantor is licensee or licensor thereunder), including, without limitation, the agreements required to be set forth on Schedule 5.2(II) under the heading “Trade Secret Licenses” (as such schedule may be amended
or supplemented from time to time). 

  
 6 

 “Trade Secrets” shall mean all trade secrets and all other
confidential or proprietary information and know-how, whether or not the foregoing has been reduced to a writing or other tangible form, including all documents and things embodying, incorporating, or referring in any way to the foregoing, and all
other similar rights of any kind accruing thereunder throughout the world. 
 “Trade Secret
Rights” shall mean the rights of any Grantor in any Trade Secret it holds. 
 “Trust
Account” shall mean account # 098084-000 maintained in Borrower’s name at Wilmington Trust Company, and any and all accounts in replacement or substitution thereof. 

“UCC” shall mean the Uniform Commercial Code as in effect from time to time in the State of New York;
provided, however, that in the event that, by reason of mandatory provisions of law, any or all of the perfection or priority of, or remedies with respect to, any Collateral is governed by the Uniform Commercial Code as enacted and in effect in a
jurisdiction other than the State of New York, the term “UCC” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions hereof relating to such perfection, priority or
remedies. 
 “United States” shall mean the United States of America. 

1.2 Definitions; Interpretation. All capitalized terms used herein (including the preamble and recitals hereto) and not otherwise
defined herein shall have the meanings ascribed thereto in the Credit Agreement or the UCC (as in effect on the date hereof). The incorporation by reference of terms defined in the Credit Agreement shall survive any termination of the Credit
Agreement until this Agreement is terminated as provided in Section 11 hereof. Any of the terms defined herein may, unless the context otherwise requires, be used in the singular or the plural, depending on the reference. References herein to
any Section, Appendix, Schedule or Exhibit shall be to a Section, an Appendix, a Schedule or an Exhibit, as the case may be, hereof unless otherwise specifically provided. The use herein of the word “include” or “including”, when
following any general statement, term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters, whether or not non-limiting
language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that fall within the broadest possible
scope of such general statement, term or matter. The terms lease and license shall include sub-lease and sub-license, as applicable. All references herein to provisions of the UCC shall include all successor provisions under any subsequent version
or amendment to any Article of the UCC 
 SECTION 2. GRANT OF SECURITY. 

2.1 Grant of Security. Each Grantor hereby grants to the Collateral Agent, for the benefit of the Secured Parties, a security
interest in and continuing Lien on all of such Grantor’s right, title and interest in, to and under all the following property interests and assets of any kind, nature or in any form whatsoever, of such Grantor, in each case whether now or
hereafter existing or in which any Grantor now has or hereafter acquires an interest and wherever the same may be located (all of which being hereinafter collectively referred to as the “Collateral”): 

(a) each and every Account; 

  
 7 

 (b) all cash, Cash Equivalents and Investments; 

(c) the Controlled Accounts and all monies, securities, Instruments and other investments deposited or required to be
deposited in the Controlled Accounts; 
 (d) all Chattel Paper (including, without limitation, all Tangible
Chattel Paper and all Electronic Chattel Paper) and promissory notes; 
 (e) all Commercial Tort Claims now or
hereafter in existence, including such claims described on Schedule 5.2(III); 
 (f) all Domain Names and Trade
Secret Rights; 
 (g) Contracts, together with all Contract Rights; 

(h) all Intellectual Property; 
 (i) all Equipment; 
 (j) all Deposit Accounts and all other demand,
deposit, time, savings, cash management, passbook and similar accounts maintained by, or for the benefit of, such Grantor with any person and all monies, securities, Instruments and other investments deposited or required to be deposited in any of
the foregoing; 
 (k) all Documents; 

(l) all General Intangibles; 
 (m) all Goods; 
 (n) all Instruments; 

(o) all Inventory; 
 (p) all Financial Assets and Investment Related Property; 
 (q) all
Letter-of-Credit Rights (whether or not the respective letter of credit is evidenced by a writing); 
 (r) all
Permits; 
 (s) all Software and all Software licensing rights, all writings, plans, specifications and
schematics, all engineering drawings, customer lists, goodwill and licenses, and all recorded data of any kind or nature, regardless of the medium of recording; 
 (t) all Supporting Obligations; 

  
 8 

 (u) all intercompany claims (including, without limitations, claims arising
from the distribution by Borrower of proceeds of the Credit Agreement); 
 (v) all Securities and all options and
warrants to purchase Securities; 
 (w) all NDAs and ANDAs and any escrow account with the Depository Bank
holding any such NDAs or ANDAs in escrow; 
 (x) all Insurance; 

(y) all Receivables and Receivables Records; 

(z) all Money; 
 (aa) all Security Entitlements in any of the foregoing; 
 (bb) to
the extent not otherwise included above, all other personal property of any kind and all Collateral Records, Collateral Support and Supporting Obligations relating to any and all of the foregoing; and 

(cc) to the extent not otherwise included above, all Proceeds, products, accessions, rents and profits of or in respect of
any and all of the foregoing. 
 2.2 Certain Limited Exclusions. Notwithstanding anything herein to the contrary,
(a) other than with respect to the NDAs and the ANDAs, in no event will the Collateral include and no Grantor will be deemed to have granted a security interest in, any of its right, title or interest (i) in any lease, license, Contract,
permit, Instrument, security, franchise or other agreement to which such Grantor is a party or any of its rights or interests thereunder, (x) to the extent, but only to the extent, that such a grant would be prohibited by any requirement of
applicable law of a government authority or (y) to the extent that such a grant would constitute a default under, or result in the breach of or termination of any such instrument or require the consent not obtained of a third party (other than
(x) to the extent that any such term would be rendered ineffective pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the UCC or any successor provision or provisions of any relevant jurisdiction or any other applicable law (including the
Bankruptcy Code) or principles of equity or (y) with respect to licenses, Contracts and other agreements with regard to Intellectual Property and negative pledge provisions contained in any lease, license, contract, permit, Instrument,
security, franchise), but any exclusion per the foregoing shall not exclude any proceeds or products of any such excluded asset and shall cease being excluded automatically upon the basis for such exclusion being eliminated; provided, that,
if requested by the Collateral Agent, each Grantor agrees to use its commercially reasonable efforts to obtain all requisite consents to enable such Grantor to provide a security interest in such asset and, in any event, immediately upon the
ineffectiveness, lapse or termination of any such provision, the Collateral will include, and such Grantor will be deemed to have granted a security interest in, all such rights and interests as if such provision had never been in effect and
(ii) any trademark application filed on an “intent to use” basis until such time as a statement of use has been filed with and duly accepted by the United States Patent and Trademark Office and (b) with respect to each direct or
indirect foreign subsidiary of Borrower (each, a “Controlled Foreign Corporation”), no assets of such Controlled Foreign Corporation shall be deemed pledged hereunder. 

  
 9 

 SECTION 3. SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE. 

3.1 Security for Obligations. This Agreement secures, and the Collateral is collateral security for, the prompt and complete
payment or performance in full when due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise, of all Obligations (the “Secured Obligations”). 

3.2 Continuing Liability Under Collateral. Notwithstanding anything herein to the contrary, (i) each Grantor shall remain
liable for all obligations under the Collateral and nothing contained herein is intended or shall be a delegation of duties to the Collateral Agent or any other Secured Party, (ii) each Grantor shall remain liable under each of the agreements
included in the Collateral, including, without limitation, any agreements relating to Pledged Partnership Interests or Pledged LLC Interests, to perform all of the obligations undertaken by it thereunder all in accordance with and pursuant to the
terms and provisions thereof and neither the Collateral Agent nor any Secured Party shall have any obligation or liability under any of such agreements by reason of or arising out of this Agreement or any other document related thereto nor shall the
Collateral Agent nor any Secured Party have any obligation to make any inquiry as to the nature or sufficiency of any payment received by it or have any obligation to take any action to collect or enforce any rights under any agreement included in
the Collateral, including, without limitation, any agreements relating to Pledged Partnership Interests or Pledged LLC Interests, and (iii) the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from
any of its duties or obligations under the contracts and agreements included in the Collateral. 
 SECTION 4. CERTAIN PERFECTION REQUIREMENTS

 4.1 Delivery Requirements. 
 (a) With respect to any Certificated Securities included in the Collateral, each Grantor shall deliver to the Collateral Agent the Security Certificates evidencing such Certificated Securities duly
indorsed by an effective indorsement (within the meaning of Section 8-107 of the UCC), or accompanied by share transfer powers or other instruments of transfer duly endorsed by such an effective endorsement, in each case, to the Collateral
Agent or in blank. The requirements of this Section 4.1(a) shall not apply to any certificates in respect of the 6% Cumulative Redeemable Preference Shares (the “Preference Shares”) in Strides Arcolab Limited
(“Strides”) held by the Borrower so long as (i) the Borrower is engaged in good faith negotiations in connection with the Strides Transaction and (ii) the Strides Transaction shall have been consummated by
December 31, 2010. 
 (b) With respect to any Instruments or Tangible Chattel Paper included in the
Collateral, each Grantor shall deliver to the Collateral Agent all such Instruments or Tangible Chattel Paper to the Collateral Agent duly indorsed in blank. 
 4.2 Control Requirements. 
 (a) Subject to Section 5.22
of the Credit Agreement with respect to any Deposit Accounts (other than any Deposit Accounts used exclusively for (i) payroll or employee benefits purposes or (ii) which have a monthly balance of less than $10,000 individually or $15,000
in the aggregate for all such accounts), Securities Accounts, Security Entitlements, Commodity Accounts and 

  
 10 

 
Commodity Contracts included in the Collateral, each Grantor shall ensure that the Collateral Agent has Control thereof. With respect to any Securities Accounts or Securities Entitlements, such
Control shall be accomplished by the Grantor causing the Securities Intermediary maintaining such Securities Account or Security Entitlement to enter into an agreement substantially in the form of Exhibit B hereto (or such other agreement in form
and substance reasonably satisfactory to the Collateral Agent), so that any such Securities Intermediary shall comply with the Collateral Agent’s Entitlement Orders without further consent by such Grantor. With respect to any Deposit Account,
each Grantor shall cause the depositary institution maintaining such account to enter into an agreement substantially in the form of Exhibit C hereto (or such other agreement in form and substance reasonably satisfactory to the Collateral Agent)
pursuant to which the Bank shall agree to comply with the Collateral Agent’s instructions with respect to disposition of funds in the Deposit Account without further consent by such Grantor. 

(b) With respect to any Uncertificated Security included in the Collateral (other than any Uncertificated Securities
credited to a Securities Account), at the request of the Collateral Agent, each Grantor shall cause the issuer of such Uncertificated Security to either (i) register the Collateral Agent as the registered owner thereof on the books and records
of the issuer or (ii) execute an agreement substantially in the form of Exhibit D hereto (or such other agreement in form and substance reasonably satisfactory to the Collateral Agent) pursuant to which such issuer shall agree to comply with
the Collateral Agent’s instructions with respect to disposition of funds in the Uncertificated Security without further consent by such Grantor. 
 (c) With respect to any Letter of Credit Rights included in the Collateral (other than any Letter of Credit Rights constituting a Supporting Obligation for a Receivable in which the Collateral Agent has a
valid and perfected security interest), Grantor shall ensure that Collateral Agent has Control thereof by making reasonable commercial efforts to obtain the written consent of each issuer of each related letter of credit to the assignment of the
proceeds of such letter of credit to the Collateral Agent. 
 (d) With respect any Electronic Chattel Paper or
“transferable record”(as that term is defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant
jurisdiction) included in the Collateral, Grantor shall make all reasonable efforts to ensure that the Collateral Agent has Control thereof. 
 4.3 Intellectual Property Recording Requirements. 

(a) In the case of any Collateral (whether now owned or hereafter acquired) consisting of
issued U.S. patents and pending applications therefor, each Grantor shall execute and deliver to the Collateral Agent a Patent Security Agreement in substantially the form of Exhibit E hereto or, on a fiscal quarterly basis, a supplement thereto
covering all such patents and pending applications therefor (in each case, to the extent not already covered by such previous Patent Security Agreement or supplements thereto) in appropriate form for recordation with the U.S. Patent and Trademark
Office with respect to the security interest of the Collateral Agent. 
 (b) In the case of any Collateral
(whether now owned or hereafter acquired) consisting of registered U.S. federally registered trademarks and pending applications therefor, each Grantor shall execute and deliver to the Collateral Agent a Trademark Security Agreement in substantially
the form of Exhibit F hereto or, on a fiscal quarterly basis, a supplement thereto covering all such trademarks and pending applications therefor (in each case, to the extent not already covered by such previous Trademark Security Agreement or
supplements thereto) in appropriate form for recordation with the U.S. Patent and Trademark Office with respect to the security interest of the Collateral Agent. 

  
 11 

 (c) In the case of any Collateral (whether now owned or hereafter acquired)
consisting of registered U.S. copyright registrations and exclusive Copyright Licenses in respect of registered U.S. Copyrights for which any Grantor is the licensee, each Grantor shall execute and deliver to the Collateral Agent a Copyright
Security Agreement in substantially the form of Exhibit G hereto or, on a fiscal quarterly basis, a supplement thereto covering all such U.S. copyright registrations and Copyright Licenses (in each case, to the extent not already covered by such
previous Copyright Security Agreement or supplements thereto) in appropriate form for recordation with the U.S. Copyright Office with respect to the security interest of the Collateral Agent. 

4.4 Other Actions. 
 (a) If any issuer of any Pledged Equity Interest is organized under a jurisdiction outside of the United States, each Grantor shall take such additional actions, reasonably requested by the Collateral
Agent, which may include, without limitation, causing the issuer to register the pledge on its books and records or making such filings or recordings, in each case as may be necessary or advisable, under the laws of such issuer’s jurisdiction
to insure the validity, perfection and priority of the security interest of the Collateral Agent. 
 (b) With
respect to any Pledged Partnership Interests and Pledged LLC Interests included in the Collateral, if the Grantors own less than 100% of the equity interests in any issuer of such Pledged Partnership Interests or Pledged LLC Interests, Grantors
shall use their commercially reasonable efforts to obtain the consent of each other holder of partnership interests or limited liability company interests in such issuer to the security interest of the Collateral Agent hereunder and following an
Event of Default, the transfer of such Pledged Partnership Interests and Pledged LLC Interests to the Collateral Agent or of its designee, and to the substitution of the Collateral Agent or its designee as a partner or member with all the rights and
powers related thereto. Each Grantor consents to the grant by each other Grantor of a Lien in all Investment Related Property to the Collateral Agent and, without limiting the generality of the foregoing, consents to the transfer of any Pledged
Partnership Interest and any Pledged LLC Interest to the Collateral Agent or its designee following an Event of Default and to the substitution of the Collateral Agent or its designee as a partner in any partnership or as a member in any limited
liability company with all the rights and powers related thereto. 
 (c) With respect to any Goods in excess of
$100,000 individually, which are covered by a certificate of title under a statute of any jurisdiction under the law of which indication of a security interest on such certificate is required as a condition of perfection thereof, upon the reasonable
request of the Collateral Agent, (A) provide information with respect to any such Goods and (B) upon the occurrence and during the continuance of an Event of Default, deliver to the Collateral Agent copies of all such applications or other
documents filed during such calendar quarter and copies of all such certificates of title issued during such calendar quarter indicating the security interest created hereunder in the items of Goods covered thereby. 

  
 12 

 SECTION 5. REPRESENTATIONS AND WARRANTIES. 
 Each Grantor hereby represents and warrants (which representations and warranties shall survive the execution and delivery of this Agreement) that: 

5.1 Grantor Information & Status. 

(a) Schedule 5.1(A) and (B) (as such schedule may be amended or supplemented from time to time) sets forth under the
appropriate headings: (1) the full legal name of such Grantor, (2) all trade names or other names under which such Grantor currently conducts business, (3) the type of organization of such Grantor, (4) the jurisdiction of
organization of such Grantor, (5) its organizational identification number, if any, and (6) the jurisdiction where the chief executive office or its sole place of business (or the principal residence if such Grantor is a natural person) is
located; 
 (b) except as provided on Schedule 5.1(C), it has not changed its name, jurisdiction of organization,
chief executive office or sole place of business (or principal residence if such Grantor is a natural person) or its corporate structure in any way (e.g., by merger, consolidation, change in corporate form or otherwise) and has not done business
under any other name, in each case, within the past three (3) years; 
 (c) it has not within the last three
(3) years become bound (whether as a result of merger or otherwise) as debtor under a security agreement entered into by another Person, which has not heretofore been terminated other than the agreements identified on Schedule 5.1(D) hereof (as
such schedule may be amended or supplemented from time to time); 
 (d) such Grantor has been duly organized and
is validly existing as an entity of the type as set forth opposite such Grantor’s name on Schedule 5.1(A) solely under the laws of the jurisdiction as set forth opposite such Grantor’s name on Schedule 5.1(A) and remains duly existing as
such. Such Grantor has not filed any certificates of dissolution or liquidation, any certificates of domestication, transfer or continuance in any other jurisdiction, except in the case of Ethex, such certificates of dissolution and other
documentation filed in accordance with the terms of Section 6.8(g) of the Credit Agreement; and 
 (e) no
Grantor is a “transmitting utility” (as defined in Section 9-102(a)(80) of the UCC). 
 5.2 Collateral
Identification, Special Collateral. 
 (a) Schedule 5.2 (as such schedule may be amended or supplemented from
time to time) sets forth under the appropriate headings all of such Grantor’s: (1) Pledged Equity Interests, (2) Pledged Debt, (3) Securities Accounts, (4) Deposit Accounts, (5) Commodity Contracts and Commodity
Accounts, (6) United States registrations and issuances of and applications for Patents, Trademarks, and Copyrights owned by each Grantor, (7) material Copyright Licenses, Patent Licenses, Trademark Licenses and Trade Secret Licenses to
which any Grantor is a party, but excluding computer software licenses and confidentiality/non-disclosure agreements, (8) Commercial Tort Claims, (9) Letter of Credit Rights for letters of credit, and (10) the name and address of any
warehouseman, bailee or other third party in possession of any Inventory, Equipment and other tangible personal property. Each Grantor shall supplement such schedules at the time of delivery of its quarterly financial statements in accordance with
the terms of the Credit Agreement; 

  
 13 

 (b) none of the Collateral constitutes, or is the Proceeds of, (1) Farm
Products, (2) As-Extracted Collateral, (3) Manufactured Homes, (4) Health-Care-Insurance Receivables; (5) timber to be cut, or (6) aircraft, aircraft engines, satellites, ships or railroad rolling stock. No material portion
of the Collateral consists of motor vehicles or other goods subject to a certificate of title statute of any jurisdiction; 
 (c) all information supplied by any Grantor with respect to any of the Collateral (in each case taken as a whole with respect to any particular Collateral) is accurate and complete in all material
respects; 
 (d) not more than 2% of the value of all tangible personal property included in the Collateral is
located in any country other than the United States; and 
 (e) no Excluded Asset (other than the Borrower’s
rights or interests under the Gestine APA prior to the Gestine Transfer (solely to the extent that such rights or interests would be deemed to be Excluded Assets)) is material to the business of such Grantor. 

5.3 Ownership of Collateral and Absence of Other Liens. 

(a) Each Grantor owns the Collateral purported to be owned by it or otherwise has the rights it purports to have in each
item of Collateral and, as to all Collateral whether now existing or hereafter acquired, developed or created (including by way of lease or license), will continue to own or have such rights in each item of the Collateral (except as otherwise
permitted by the Credit Agreement, or, with respect to Intellectual Property, to the extent such Intellectual Property expires by its statutory term or, in the Grantor’s reasonable business judgment, ceases to be a Material Intellectual
Property), in each case free and clear of any and all Liens, rights or claims of all other Persons, including, without limitation, Liens arising as a result of such Grantor becoming bound (as a result of merger or otherwise) as debtor under a
security agreement entered into by another Person, other than any Permitted Liens; and 
 (b) other than any
financing statements filed in favor of the Collateral Agent, no effective financing statement, fixture filing or other instrument similar in effect under any applicable law covering all or any part of the Collateral is on file in any filing or
recording office except for (x) financing statements for which duly authorized proper termination statements have been delivered to the Collateral Agent for filing and (y) financing statements filed in connection with Permitted Liens.
Other than the Collateral Agent and any automatic control in favor of a Bank, Securities Intermediary or Commodity Intermediary maintaining a Deposit Account, Securities Account or Commodity Contract, no Person is in Control of any Collateral (other
than with respect to (x) the Preference Shares, (y) prior to the satisfaction of the obligations set forth in Section 5.22 of the Credit Agreement, any shares representing up to 35% of the voting shares of KV Pharmaceutical Company
Limited, DrugTech Sàrl and Nesher Solutions Limited and (z) any bank accounts of the Grantors which are not subject to the control of the Collateral Agent pursuant to the terms of the Credit Documents. 

5.4 Status of Security Interest. 
 (a) upon the filing of financing statements naming each Grantor as “debtor” and the Collateral Agent as “secured party” and describing the Collateral in the filing offices set forth
opposite such Grantor’s name on Schedule 5.4 hereof (as such schedule may be amended or supplemented from 

  
 14 

 
time to time), the security interest of the Collateral Agent in all Collateral that can be perfected by the filing of a financing statement under the Uniform Commercial Code as in effect in such
jurisdiction will constitute a valid and perfected security interest, prior to any other Lien on such Collateral other than any Permitted Liens. Each agreement purporting to give the Collateral Agent Control over any Collateral is effective to
establish the Collateral Agent’s Control of the Collateral subject thereto; 
 (b) to the extent perfection
or priority of the security interest therein is not subject to Article 9 of the UCC, and upon recordation of the security interests granted pursuant to the Intellectual Property Security Agreements in the U.S. Patent and Trademark Office and the
U.S. Copyright Office, the security interests granted to the Collateral Agent hereunder shall constitute valid, perfected, First Priority Liens in the United States with respect to the Intellectual Property covered by such Intellectual Property
Security Agreements; and 
 (c) no authorization, consent, approval or other action by, and no notice to or
filing with, any Governmental Authority or regulatory body or any other Person is required for either (i) the pledge or grant by any Grantor of the Liens purported to be created in favor of the Collateral Agent hereunder or (ii) the
exercise by Collateral Agent of any rights or remedies in respect of any Collateral (whether specifically granted or created hereunder or created or provided for by applicable law), except (A) for the filings contemplated by clause
(a) above, (B) as may be required, in connection with the disposition of any Investment Related Property, by laws generally affecting the offering and sale of Securities and (C) as set forth on Schedule 5.22 to the Credit Agreement.

 5.5 Goods & Receivables. 

(a) each Receivable (i) is and will be the legal, valid and binding obligation of the Account Debtor in respect
thereof, representing an unsatisfied obligation of such Account Debtor, (ii) is and will be enforceable in accordance with its terms, (iii) is not and will not be subject to any credits, rights of recoupment, setoffs, defenses, taxes,
counterclaims except in the Ordinary Course of Business and (iv) is and will be in compliance in all material respects with all applicable laws, whether federal, state, local or foreign; 

(b) except as set forth in Schedule 5.5, none of the Account Debtors in respect of any Receivable is the government of the
United States, any agency or instrumentality thereof, any state or municipality or any foreign sovereign. No Receivable requires the consent of the Account Debtor in respect thereof in connection with the security interest hereunder, except any
consent which has been obtained; 
 (c) no Goods now or hereafter produced by any Grantor and included in the
Collateral have been or will be produced in violation of the requirements of the Fair Labor Standards Act, as amended, or the rules and regulations promulgated thereunder; and 

(d) all of the Equipment and Inventory included in the Collateral is located only at the locations specified in Schedule
5.5 (as such schedule may be amended or supplemented from time to time). 

  
 15 

 5.6 Pledged Equity Interests, Investment Related Property. 

(a) such Grantor is the record and beneficial owner of the Pledged Equity Interests free of all Liens, rights or claims of
other Persons and there are no outstanding warrants, options or other rights to purchase, or shareholder, voting trust or similar agreements outstanding with respect to, or property that is convertible into, or that requires the issuance or sale of,
any Pledged Equity Interests, other than any Permitted Liens; 
 (b) no consent of any Person including any other
general or limited partner, any other member of a limited liability company, any other shareholder or any other trust beneficiary is necessary in connection with the creation, perfection or priority status of the security interest (except for any
Permitted Lien) of the Collateral Agent in any Pledged Equity Interests or the exercise by the Collateral Agent of the voting or other rights provided for in this Agreement or the exercise of remedies in respect thereof except such as have been
obtained; and 
 (c) all of the Pledged LLC Interests and Pledged Partnership Interests are or represent
interests that by their terms provide that they are securities governed by the uniform commercial code of an applicable jurisdiction. 
 5.7 Intellectual Property. 
 (a) except as set forth on
Schedule 5.7, no holding, decision, ruling, or judgment has been rendered in any action or proceeding before any court or administrative authority challenging the validity, enforceability, or scope of, or such Grantor’s right to register, own
or use, any Material Intellectual Property owned by or, to such Grantor’s knowledge, exclusively licensed to, such Grantor, and no such action or proceeding is pending or, to such Grantor’s knowledge, threatened, in each case, other than
office actions or similar actions issued in the ordinary course of prosecutions; 
 (b) all registrations,
issuances and applications for Copyrights, Patents and Trademarks owned by such Grantor are standing in the name of such Grantor, and none of the Trademarks, Patents, Copyrights or Trade Secrets owned by such Grantor has been licensed by such
Grantor to any Affiliate or third party, except as permitted under the Credit Agreement, and any exclusive Copyright Licenses for which any Grantor is the licensee constituting Material Intellectual Property in respect of registered U.S. Copyrights
have been properly recorded in the U.S. Copyright Office; 
 (c) except as permitted by the Credit Agreement,
such Grantor has not made a previous assignment, sale, transfer, exclusive license, or similar arrangement constituting a future assignment, sale, transfer, exclusive license or similar arrangement of any Material Intellectual Property that has not
been terminated or released; 
 (d) such Grantor has used commercially reasonable efforts to use
(i) appropriate statutory notice of registration in connection with its use of registered U.S. Trademarks owned or exclusively licensed to such Grantor, and (ii) appropriate notice of copyright in connection with the publication of
material Copyrights owned or exclusively licensed to such Grantor, and such Grantor has not used marking practices in connection with its use of material Patents, Trademarks or Copyrights, in each case owned or exclusively licensed to such Grantor,
that would jeopardize and/or impair, in any material respect, the value of such Intellectual Property; 
 (e)
such Grantor has taken commercially reasonable efforts to protect the confidentiality of Trade Secrets owned by such Grantor and has not disclosed any material Trade Secrets to any third party unless such third party is subject to a valid and
enforceable agreement providing for the confidentiality of the same; 

  
 16 

 (f) such Grantor controls the nature and quality of all products sold and
all services rendered under or in connection with all material Trademarks owned by such Grantor, in each case substantially consistent with industry standards, and has taken all commercially reasonable action to insure that all licensees of the
material Trademarks owned by such Grantor comply with such Grantor’s standards of quality; and 
 (g) except
as set forth in Schedule 5.7, no settlement or consents, covenants not to sue, co-existence agreements, non-assertion assurances, or releases have been entered into by such Grantor or bind such Grantor in a manner that would reasonably be expected
to adversely affect such Grantor’s rights to own, license or use any Intellectual Property in any material respect. 

5.8 Secured Obligations. 
 The provisions of this Agreement are effective to create in favor of the Collateral Agent, for the benefit of the Secured Parties, legal, valid and perfected Liens on and security interests (having the
priority provided for herein) in all right, title and interest in the Collateral, enforceable against each Grantor. 
 5.9
Miscellaneous. 
 Except as set forth on the schedules to the Perfection Certificate, no Material Contract
prohibits assignment or requires consent of or notice to any Person in connection with the assignment to the Collateral Agent hereunder, except such as has been given or made. 
 SECTION 6. COVENANTS AND AGREEMENTS. 
 As long as the Obligations remain outstanding (other
than contingent obligations not yet due and payable) each Grantor hereby covenants and agrees (which covenants and agreements shall survive the execution and delivery of this Agreement) that: 

6.1 Grantor Information and Status. 
 Without limiting any prohibitions or restrictions on mergers or other transactions set forth in the Credit Agreement, it shall not change such Grantor’s name, identity, corporate structure (e.g. by
merger, consolidation, change in corporate form or otherwise), sole place of business, chief executive office, type of organization or jurisdiction of organization or establish any trade names unless it shall have (a) notified the Collateral
Agent in writing at least thirty (30) days prior to any such change or establishment, identifying such new proposed name, identity, corporate structure, sole place of business (or principal residence if such Grantor is a natural person), chief
executive office, jurisdiction of organization or trade name and providing such other information in connection therewith as the Collateral Agent may reasonably request and (b) taken all actions reasonably necessary or advisable to maintain the
continuous validity, perfection and the same or better priority of the Collateral Agent’s security interest in the Collateral granted or intended to be granted and agreed to hereby, which in the case of any merger or other change in corporate
structure shall include, without limitation, executing and delivering to the 

  
 17 

 
Collateral Agent a completed Pledge Supplement together with all supplements to schedules thereto, upon completion of such merger or other change in corporate structure confirming the grant of
the security interest hereunder; provided that, the transactions permitted pursuant to Section 5.23(e) of the Credit Agreement with respect to Ethex shall not be prohibited by this Section 6.1. 

6.2 Collateral Identification; Special Collateral. 

(a) in the event that it hereafter acquires any Collateral of a type described in Section 5.2(b) hereof, it shall
promptly notify the Collateral Agent thereof in writing and take such actions and execute such documents and make such filings all at Grantor’s expense as the Collateral Agent may reasonably request in order to ensure that the Collateral Agent
has a valid, perfected, First Priority security interest in such Collateral. 
 (b) in the event that it
hereafter acquires or has any Commercial Tort Claim it shall deliver to the Collateral Agent a completed Pledge Supplement together with all supplements to schedules thereto, identifying such new Commercial Tort Claims. 

6.3 Ownership of Collateral and Absence of Other Liens. 

(a) Except for the security interest created by this Agreement, such Grantor shall not create or suffer to exist any Lien
upon or with respect to any of the Collateral, other than Permitted Liens, and such Grantor shall defend the Collateral against all Persons at any time claiming any interest therein; 

(b) the applicable Grantor shall promptly notify the Collateral Agent if any material portion of the Collateral is damaged
or destroyed or otherwise impaired or adversely affected; and 
 (c) it shall not sell, abandon, transfer or
otherwise dispose of or assign (by operation of law or otherwise) or license to another Person any Collateral except as otherwise permitted by the Credit Agreement. 
 6.4 Status of Security Interest. Subject to the terms of the Credit Agreement and this Agreement, each Grantor shall maintain the security interest of the Collateral Agent hereunder in all
Collateral as a valid and perfected security interest, prior to any other Lien on such Collateral other than any Permitted Liens. 
 6.5 Goods and Receivables. 
 (a) Such Grantor shall not
deliver any Document evidencing any Equipment and Inventory to any Person other than the issuer of such Document to claim the Goods evidenced therefor or the Collateral Agent; 

(b) if any Equipment or Inventory in excess of $25,000 individually or $1,000,000 in the aggregate (based on its book
value) is in the possession or control of any warehouseman, bailee or other third party or is located at a site leased by Borrower or one of its Subsidiaries (other than a 

  
 18 

 
Consignee under a Consignment for which such Grantor is the Consignor), each Grantor shall join with the Collateral Agent in notifying the third party or landlord of the Collateral Agent’s
security interest; provided that, with respect to any warehousemen, bailees or other third parties holding any such Equipment or Inventory as of the Closing Date, the such notification shall be made within 10 days after the Closing Date or
such longer period of time as consented to by the Collateral Agent in its reasonable discretion and (x) with respect to each such warehouseman, bailee or other third party, at the request of the Collateral Agent, such Grantor shall use its
commercially reasonable efforts to obtain an acknowledgment from such warehouseman, bailee or other third party that it is holding the Equipment and Inventory for the benefit of the Collateral Agent and will permit the Collateral Agent to have
access to Equipment or Inventory for purposes of inspecting such Collateral or, following an Event of Default, to remove the same from such premises if the Collateral Agent so elects and (y) with respect to each such landlord, such Grantor
shall use its commercially reasonable efforts to obtain a Landlord Waiver and Consent Agreement; and with respect to any Goods in excess of $25,000 individually subject to a Consignment for which such Grantor is the Consignor, Grantor shall file
appropriate financing statements against the Consignee and take such other reasonable actions as may be necessary to ensure that the Grantor has a valid and perfected security interest (prior to any other Lien on such Collateral other than any
Permitted Liens) in such Goods; provided that, with respect to any such Goods of the Grantor as of the Closing Date, the Grantor shall take such actions within 30 days after the Closing Date or such longer period of time as consented to by
the Collateral Agent in its reasonable discretion; 
 (c) it shall keep the Equipment, Inventory and any
Documents evidencing any Equipment and Inventory in the locations specified on Schedule 5.5 (as such schedule may be amended or supplemented from time to time) unless it shall have notified the Collateral Agent in writing, by executing and
delivering to the Collateral Agent a completed Pledge Supplement together with all supplements to schedules thereto, at least five (5) days prior to any change in locations, identifying such new locations and providing such other information in
connection therewith as the Collateral Agent may reasonably request; 
 (d) it shall keep and maintain at its own
cost and expense satisfactory and complete records of the Receivables, including, but not limited to, the originals of all documentation with respect to all Receivables and records of all payments received and all credits granted on the Receivables,
all merchandise returned and all other dealings therewith; 
 (e) other than in the ordinary course of business
(i) it shall not amend, modify, terminate or waive any provision of any Receivable in any manner which could reasonably be expected to have a Material Adverse Effect on the value of such Receivable; (ii) following and during the
continuation of an Event of Default, such Grantor shall not (w) grant any extension or renewal of the time of payment of any Receivable, (x) compromise or settle any dispute, claim or legal proceeding with respect to any Receivable for
less than the total unpaid balance thereof, (y) release, wholly or partially, any Person liable for the payment thereof, or (z) allow any credit or discount thereon; and 

(f) the Collateral Agent shall have the right to require any Grantor to notify (and in the event that such Grantor fails
to so notify, the Collateral Agent shall have the right to notify) any Account Debtor of the Collateral Agent’s security interest in the Receivables and any Supporting Obligation and, in addition, at any time following the occurrence and during
the continuation of an Event of Default, the Collateral Agent may: (i) direct the Account Debtors under any Receivables to make payment of all amounts due or to become due to such Grantor thereunder directly to the Collateral Agent;
(ii) notify, or require any Grantor to notify, each Person maintaining a lockbox or similar arrangement to which Account Debtors under any Receivables have been directed to make payment to remit all amounts representing collections on checks
and other payment items from time to time sent to or deposited in such lockbox or other arrangement directly to the Collateral Agent; and (iii) enforce, at the expense of such 

  
 19 

 
Grantor, collection of any such Receivables and to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might have done. If the
Collateral Agent notifies any Grantor that it has elected to collect the Receivables in accordance with the preceding sentence, any payments of Receivables received by such Grantor shall be forthwith (and in any event within three (3) Business
Days) deposited by such Grantor in the exact form received, duly indorsed by such Grantor to the Collateral Agent if required, in the Collateral Account maintained under the sole dominion and control of the Collateral Agent, and until so turned
over, all amounts and proceeds (including checks and other instruments) received by such Grantor in respect of the Receivables, any Supporting Obligation or Collateral Support shall be received in trust for the benefit of the Collateral Agent
hereunder and shall be segregated from other funds of such Grantor and such Grantor shall not adjust, settle or compromise the amount or payment of any Receivable, or release wholly or partly any Account Debtor or obligor thereof, or allow any
credit or discount thereon. 
 6.6 Pledged Equity Interests, Investment Related Property. 

(a) except as provided in the next sentence, in the event such Grantor receives any dividends, interest or distributions
on any Pledged Equity Interest or other Investment Related Property, upon the merger, consolidation, liquidation or dissolution of any issuer of any Pledged Equity Interest or Investment Related Property, then (a) such dividends, interest or
distributions and securities or other property shall be included in the definition of Collateral without further action and (b) such Grantor shall immediately take all steps, if any, necessary or advisable to ensure the validity, perfection,
priority and, if applicable, control of the Collateral Agent over such Investment Related Property (including, without limitation, delivery thereof to the Collateral Agent) and pending any such action such Grantor shall be deemed to hold such
dividends, interest, distributions, securities or other property in trust for the benefit of the Collateral Agent and shall segregate such dividends, distributions, Securities or other property from all other property of such Grantor.
Notwithstanding the foregoing, so long as no Event of Default shall have occurred and be continuing, the Collateral Agent authorizes each Grantor to retain all ordinary cash dividends and distributions paid in the normal course of the business of
the issuer and consistent with the past practice of the issuer and all scheduled payments of interest; 
 (b)

 (i) So long as no Event of Default shall have occurred and be continuing, except as otherwise provided under
the covenants and agreements relating to Investment Related Property in this Agreement or elsewhere herein or in the Credit Agreement, each Grantor shall be entitled to exercise or refrain from exercising any and all voting and other consensual
rights pertaining to the Investment Related Property or any part thereof for any purpose not inconsistent with the terms of this Agreement or the Credit Agreement; provided, no Grantor shall exercise or refrain from exercising any such right
if the Collateral Agent shall have notified such Grantor that, in the Collateral Agent’s reasonable judgment made in good faith, such action would result in a material decline in the value of the Investment Related Property or any material part
thereof; it being understood, however, that neither the voting by such Grantor of any Pledged Stock for, or such Grantor’s consent to, the election of directors (or similar governing body) at a regularly scheduled annual or other meeting of
stockholders or with respect to incidental matters at any such meeting, nor such Grantor’s consent to or approval of any action otherwise permitted under this Agreement and the Credit Agreement, shall be deemed inconsistent with the terms of
this Agreement or the Credit Agreement within the meaning of this Section 6.6(b)(i); and 

  
 20 

 (ii) Upon the occurrence and during the continuation of an Event of Default:

  

	 	(1)	all rights of each Grantor to exercise or refrain from exercising the voting and other consensual rights which it would otherwise be entitled to exercise pursuant
hereto shall cease and all such rights shall thereupon become vested in the Collateral Agent who shall thereupon have the sole right to exercise such voting and other consensual rights; and 

 

	 	(2)	in order to permit the Collateral Agent to exercise the voting and other consensual rights which it may be entitled to exercise pursuant hereto and to receive all
dividends and other distributions which it may be entitled to receive hereunder: (1) each Grantor shall promptly execute and deliver (or cause to be executed and delivered) to the Collateral Agent all proxies, dividend payment orders and other
instruments as the Collateral Agent may from time to time reasonably request and (2) each Grantor acknowledges that the Collateral Agent may utilize the power of attorney set forth in Section 8.1. 

(c) except as expressly permitted by the Credit Agreement, without the prior written consent of the Collateral Agent, it
shall not vote to enable or take any other action to: (i) amend or terminate any partnership agreement, limited liability company agreement, certificate of incorporation, by-laws or other organizational documents in any way that materially
changes the rights of such Grantor with respect to any Investment Related Property or materially and adversely affects the validity, perfection or priority of the Collateral Agent’s security interest, (ii) permit any issuer of any Pledged
Equity Interest to issue any additional stock, partnership interests, limited liability company interests or other equity interests of any nature or to issue securities convertible into or granting the right of purchase or exchange for any stock or
other equity interest of any nature of such issuer, (iii) other than as permitted under the Credit Agreement, permit any issuer of any Pledged Equity Interest to dispose of all or a material portion of their assets, (iv) waive any default
under or breach of any terms of organizational document relating to the issuer of any Pledged Equity Interest or the terms of any Pledged Debt, or (v) cause any issuer of any Pledged Partnership Interests or Pledged LLC Interests which are not
securities (for purposes of the UCC) on the date hereof to elect or otherwise take any action to cause such Pledged Partnership Interests or Pledged LLC Interests to be treated as securities for purposes of the UCC; provided, however,
notwithstanding the foregoing, if any issuer of any Pledged Partnership Interests or Pledged LLC Interests takes any such action in violation of the foregoing in this clause (e), such Grantor shall promptly notify the Collateral Agent in writing of
any such election or action and, in such event, shall take all steps necessary or advisable to establish the Collateral Agent’s “control” thereof; and 

(d) except as expressly permitted by the Credit Agreement, without the prior written consent of the Collateral Agent, it
shall not permit any issuer of any Pledged Equity Interest to merge or consolidate unless (i) such issuer creates a security interest that is perfected by a filed financing statement (that is not effective solely under section 9-508 of the UCC)
in collateral in which such new debtor has or acquires rights, (ii) all the outstanding capital stock or other equity interests of the surviving or resulting corporation, limited liability company, partnership or other entity is, upon such
merger or consolidation, pledged hereunder and no cash, securities or other property is distributed in respect of the outstanding equity interests of any other constituent Grantor and (iii) Grantor promptly complies with the delivery and
control requirements of Section 4 hereof. 
 6.7 Intellectual Property. 

(a) such Grantor shall not do any act or omit to do any act whereby any of the Material Intellectual Property and, whether
or not the same would be deemed to be Material Intellectual Property at any given time, any of the Specified Intellectual Property, may lapse, or become abandoned, canceled, dedicated to the public (other than at the end of its statutory term),
forfeited, unenforceable or otherwise impaired, or which would adversely affect the validity, grant, or enforceability of the security interest granted therein; 

  
 21 

 (b) such Grantor, such Grantor shall not, with respect to any Trademarks
owned by such Grantor and constituting Material Intellectual Property, or, whether or not the same would be deemed to be Material Intellectual Property at any given time, constituting Specified Intellectual Property, cease the use of any of such
Trademarks or fail to maintain the level of the quality of products sold and services rendered under any of such Trademark at a level at least substantially consistent with the quality of such products and services as of the date hereof, and such
Grantor shall take all commercially reasonable steps to insure that licensees of such Trademarks use such consistent standards of quality; 
 (c) such Grantor shall promptly notify the Collateral Agent if it knows that any item of Material Intellectual Property, or, whether or not the same would be deemed to be Material Intellectual Property at
any given time, any item of Specified Intellectual Property, may become (i) abandoned or dedicated to the public or placed in the public domain (other than at the end of such item’s statutory term), (ii) invalid or unenforceable,
(iii) subject to any materially adverse determination or development regarding such Grantor’s ownership, registration or use or the validity or enforceability of such item of Material Intellectual Property or Specified Intellectual
Property (including the institution of, or any materially adverse development with respect to, any action or proceeding in the U.S. Patent and Trademark Office, the U.S. Copyright Office, any state registry, any foreign counterpart of the foregoing,
or any court, but excluding typical day-to-day developments during the prosecution of any such Intellectual Property) or (iv) the subject of any reversion or termination rights; 

(d) such Grantor shall take all commercially reasonable steps, including in any proceeding before the U.S. Patent and
Trademark Office, the U.S. Copyright Office, any state registry or any foreign counterpart of the foregoing, to pursue any application and maintain any registration or issuance of each Trademark, Patent, and Copyright owned by or exclusively
licensed to such Grantor and included in the Material Intellectual Property to the extent permitted or required by the applicable license agreement; 
 (e) subject to the effect of the applicable bankruptcy laws and other laws, such Grantor shall use commercially reasonable efforts so as not to permit the inclusion in any Contract to which it hereafter
becomes a party of any provision that could or may in any way materially impair or prevent the creation of a security interest in, or the assignment of, such Grantor’s rights and interests in any property acquired under such contracts and
included in the Material Intellectual Property, except for restrictions on transferability in leases or licenses where such Grantor believes, in its reasonable judgment, that such prohibition is usual and customary in transactions of such type;

 (f) in the event that, to such Grantor’s knowledge, any Material Intellectual Property owned by or
exclusively licensed to any Grantor is infringed, misappropriated, diluted or otherwise violated by a third party, such Grantor shall promptly take all commercially reasonable actions to stop such infringement, misappropriation, dilution or other
violation and protect its rights in such Material Intellectual Property including, but not limited to, the initiation of a suit for injunctive relief and to recover damages (with respect to exclusively licensed Intellectual Property, to the extent
permitted by the terms of the applicable license agreement); 
 (g) such Grantor shall use commercially
reasonable efforts to protect the secrecy of all Trade Secrets owned by such Grantor, including, without limitation, entering into confidentiality agreements with employees and consultants and labeling and restricting access to secret information
and documents; 

  
 22 

 (h) such Grantor shall use commercially reasonable efforts to use
(i) appropriate statutory notice of registration in connection with its use of registered U.S. Trademarks owned or exclusively licensed to such Grantor, and (ii) appropriate notice of copyright in connection with the publication of
material Copyrights owned or exclusively licensed to such Grantor, and such Grantor shall not sue marking practices in connection with its use of material Patents, Trademarks or Copyrights, in each case owned or exclusively licensed to such Grantor,
that would jeopardize and/or impair, in any material respect, the value of such Intellectual Property; and 
 (i)
such Grantor shall continue to collect, at its own expense, all amounts due or to become due to such Grantor in respect of the Intellectual Property or any portion thereof. In connection with such collections, such Grantor may take (and, at the
Collateral Agent’s reasonable direction, shall take) such action as such Grantor or the Collateral Agent may deem reasonably necessary or advisable to enforce collection of such amounts. Notwithstanding the foregoing, upon the occurrence and
continuation of an Event of Default, the Collateral Agent shall have the right at any time, to notify, or require any Grantor to notify, any obligors with respect to any such amounts of the existence of the security interest created hereby.

 SECTION 7. FURTHER ASSURANCES; ADDITIONAL GRANTORS. 
 7.1 Further Assurances. 
 (a) Each Grantor agrees that from
time to time, at the expense of such Grantor, that it shall promptly execute and deliver all further instruments and documents, and take all further action, that may be necessary, or that the Collateral Agent may reasonably request, in order to
create and/or maintain the validity, perfection or priority of and protect any security interest granted or purported to be granted hereby or to enable the Collateral Agent to exercise and enforce its rights and remedies hereunder with respect to
any Collateral. Without limiting the generality of the foregoing, each Grantor shall: 
 (i) file such financing
or continuation statements, or amendments thereto, record security interests in Intellectual Property included in the Collateral and execute and deliver such other agreements, instruments, endorsements, powers of attorney or notices as the
Collateral Agent may reasonably request, in order to effect, reflect, perfect and preserve the security interests granted or purported to be granted hereby; 
 (ii) take all actions necessary to ensure the recordation of appropriate evidence of the Liens and security interest granted hereunder in any Intellectual Property included in the Collateral with the U.S.
Patent and Trademark Office or the U.S. Copyright Office; 
 (iii) at the Collateral Agent’s reasonable
request, appear in and defend any action or proceeding that may materially affect such Grantor’s title to or the Collateral Agent’s security interest in all or any material part of the Collateral; and 

(iv) furnish the Collateral Agent with such information regarding the Collateral, including, without limitation, the
location thereof, as the Collateral Agent may reasonably request from time to time. 
 (b) Each Grantor hereby
authorizes the Collateral Agent to file a Record or Records, including, without limitation, financing or continuation statements, Intellectual Property Security Agreements and amendments and supplements to any of the foregoing, in any jurisdictions
and with any 

  
 23 

 
filing offices as the Collateral Agent may determine, in its reasonable discretion, are necessary or advisable to perfect or otherwise protect the security interest granted to the Collateral
Agent herein. Such financing statements may describe the Collateral in the same manner as described herein or may contain an indication or description of collateral that describes such property in any other manner as the Collateral Agent may
determine, in its reasonable discretion, is necessary, advisable or prudent to ensure the perfection of the security interest in the Collateral granted to the Collateral Agent herein, including, without limitation, describing such property as
“all assets, whether now owned or hereafter acquired, developed or created” or words of similar effect. Each Grantor shall furnish to the Collateral Agent from time to time statements and schedules further identifying and describing the
Collateral as the Collateral Agent may reasonably request, all in reasonable detail. 
 (c) Each Grantor hereby
authorizes the Collateral Agent to modify this Agreement after obtaining such Grantor’s approval of or signature to such modification by amending Schedule 5.2 (as such schedule may be amended or supplemented from time to time) to include
reference to any right, title or interest in any existing Intellectual Property or any Intellectual Property acquired or developed by any Grantor after the execution hereof or to delete any reference to any right, title or interest in any
Intellectual Property in which any Grantor no longer has or claims any right, title or interest. 
 7.2 Additional
Grantors. From time to time subsequent to the date hereof, additional Persons may become parties hereto as additional Grantors (each, an “Additional Grantor”), by executing a Pledge Supplement. Upon delivery of any such Pledge
Supplement to the Collateral Agent, notice of which is hereby waived by Grantors, each Additional Grantor shall be a Grantor and shall be as fully a party hereto as if Additional Grantor were an original signatory hereto. Each Grantor expressly
agrees that its Obligations arising hereunder shall not be affected or diminished by the addition or release of any other Grantor hereunder, nor by any election of Collateral Agent not to cause any Subsidiary of Borrower to become an Additional
Grantor hereunder. This Agreement shall be fully effective as to any Grantor that is or becomes a party hereto regardless of whether any other Person becomes or fails to become or ceases to be a Grantor hereunder. 

SECTION 8. COLLATERAL AGENT APPOINTED ATTORNEY-IN-FACT. 
 8.1 Power of Attorney. Each Grantor hereby irrevocably appoints the Collateral Agent (such appointment being coupled with an interest) as such Grantor’s attorney-in-fact, with full authority
in the place and stead of such Grantor and in the name of such Grantor, the Collateral Agent or otherwise, from time to time in the Collateral Agent’s discretion to take any appropriate action and to execute any instrument that the Collateral
Agent may deem reasonably necessary or advisable to accomplish the purposes of this Agreement, including, without limitation, the following: 
 (a) upon the occurrence and during the continuance of any Event of Default, to obtain and adjust insurance required to be maintained by such Grantor or paid to the Collateral Agent pursuant to the Credit
Agreement; 
 (b) upon the occurrence and during the continuance of any Event of Default, to ask for, demand,
collect, sue for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any of the Collateral; 

  
 24 

 (c) upon the occurrence and during the continuance of any Event of Default,
to receive, endorse and collect any drafts or other instruments, documents and chattel paper in connection with clause (b) above; 
 (d) upon the occurrence and during the continuance of any Event of Default, to file any claims or take any action or institute any proceedings that the Collateral Agent may deem necessary or desirable for
the collection of any of the Collateral or otherwise to enforce the rights of the Collateral Agent with respect to any of the Collateral; 
 (e) to prepare and file any UCC financing statements against such Grantor as debtor in accordance with the terms of this Agreement and the other Credit Documents; 

(f) to prepare, sign, and file for recordation in any intellectual property registry, appropriate evidence of the Lien and
security interest granted herein in any Intellectual Property owned by any Grantor or exclusive Copyright Licenses in respect of U.S. registered Copyrights for which any Grantor is licensee in the name of such Grantor as debtor in accordance with
the terms of this Agreement and the other Credit Documents; 
 (g) upon the occurrence and during the continuance
of any Event of Default, to take or cause to be taken all actions necessary to perform or comply or cause performance or compliance with the terms of this Agreement, including, without limitation, access to pay or discharge taxes or Liens (other
than Permitted Liens) levied or placed upon or threatened against the Collateral, the legality or validity thereof and the amounts necessary to discharge the same to be determined by the Collateral Agent in its reasonable discretion, any such
payments made by the Collateral Agent to become Obligations of such Grantor to the Collateral Agent, due and payable immediately without demand; and 
 (h) upon the occurrence and during the continuance of any Event of Default, generally to sell, transfer, lease, license, pledge, make any agreement with respect to or otherwise deal with any of the
Collateral as fully and completely as though the Collateral Agent were the absolute owner thereof for all purposes, and to do, at the Collateral Agent’s option and such Grantor’s expense, at any time or from time to time, all acts and
things that the Collateral Agent deems reasonably necessary to protect, preserve or realize upon the Collateral and the Collateral Agent’s security interest therein in order to effect the intent of this Agreement, all as fully and effectively
as such Grantor might do. 
 8.2 No Duty on the Part of Collateral Agent or Secured Parties. The powers conferred on the
Collateral Agent hereunder are solely to protect the interests of the Secured Parties in the Collateral and shall not impose any duty upon the Collateral Agent or any other Secured Party to exercise any such powers, except to exercise reasonable
care with respect to the custody of the Collateral. The Collateral Agent and the other Secured Parties shall be accountable only for amounts that they actually receive as a result of the exercise of such powers, and neither they nor any of their
officers, directors, employees or agents shall be responsible to any Grantor for any act or failure to act hereunder, except for their own gross negligence or willful misconduct. 

8.3 Appointment Pursuant to Credit Agreement. The Collateral Agent has been appointed as collateral agent pursuant to the Credit
Agreement. The rights, duties, privileges, immunities and indemnities of the Collateral Agent hereunder are subject to the provisions of the Credit Agreement. 

  
 25 

 SECTION 9. REMEDIES. 
 9.1 Generally. Subject to the provisions of the Credit Agreement: 
 (a) If any Event of Default shall have occurred and be continuing, subject to subsection (e) below, the Collateral Agent may exercise in respect of the Collateral, in addition to all other rights and
remedies provided for herein or otherwise available to it at law or in equity, all the rights and remedies of the Collateral Agent on default under the UCC (whether or not the UCC applies to the affected Collateral) to collect, enforce or satisfy
any Secured Obligations then owing, whether by acceleration or otherwise, and also may pursue any of the following separately, successively or simultaneously: 
 (i) require any Grantor to, and each Grantor hereby agrees that it shall at its expense and promptly upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as directed by
the Collateral Agent and make it available to the Collateral Agent at a place to be designated by the Collateral Agent that is reasonably convenient to both parties; 

(ii) enter onto the property where any Collateral is located and take possession thereof with or without judicial process;

 (iii) prior to the disposition of the Collateral, store, process, repair or recondition the Collateral or
otherwise prepare the Collateral for disposition in any manner to the extent the Collateral Agent deems appropriate; 
 (iv) without notice except as specified below or under the UCC, sell, assign, lease, license (on an exclusive or nonexclusive basis) or otherwise dispose of the Collateral or any part thereof in one or
more parcels at public or private sale, at any of the Collateral Agent’s offices or elsewhere, for cash, on credit or for future delivery, at such time or times and at such price or prices and upon such other terms as the Collateral Agent may
deem commercially reasonable; and 
 (v) exercise voting and other consensual rights with respect to the
Investment Related Property. 
 (b) The Collateral Agent or any other Secured Party may be the purchaser of any
or all of the Collateral at any public or private (to the extent the portion of the Collateral being privately sold is of a kind that is customarily sold on a recognized market or the subject of widely distributed standard price quotations) sale in
accordance with the UCC and the Collateral Agent, as collateral agent for and representative of the Secured Parties, shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the
Collateral sold at any such sale made in accordance with the UCC, to use and apply any of the Secured Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent at such sale. Each purchaser at any
such sale shall hold the property sold absolutely free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by applicable law) all rights of redemption, stay and/or appraisal which it now has or
may at any time in the future have under any rule of law or statute now existing or hereafter enacted. Each Grantor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days notice to such Grantor of the time
and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale of Collateral regardless of notice of sale having been given.
The 

  
 26 

 
Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and
place to which it was so adjourned. Each Grantor agrees that it would not be commercially unreasonable for the Collateral Agent to dispose of the Collateral or any portion thereof by using Internet sites that provide for the auction of assets of the
types included in the Collateral or that have the reasonable capability of doing so, or that match buyers and sellers of assets. Each Grantor hereby waives any claims against the Collateral Agent arising by reason of the fact that the price at which
any Collateral may have been sold at such a private sale was less than the price which might have been obtained at a public sale, even if the Collateral Agent accepts the first offer received and does not offer such Collateral to more than one
offeree. If the proceeds of any sale or other disposition of the Collateral are insufficient to pay all the Secured Obligations, Grantors shall be liable for the deficiency and the reasonable fees of any attorneys employed by the Collateral Agent to
collect such deficiency. Each Grantor further agrees that a breach of any of the covenants contained in this Section will cause irreparable injury to the Collateral Agent, that the Collateral Agent has no adequate remedy at law in respect of such
breach and, as a consequence, that each and every covenant contained in this Section shall be specifically enforceable against such Grantor, and such Grantor hereby waives and agrees not to assert any defenses against an action for specific
performance of such covenants except for a defense that no default has occurred giving rise to the Secured Obligations becoming due and payable prior to their stated maturities. Nothing in this Section shall in any way limit the rights of the
Collateral Agent hereunder. 
 (c) The Collateral Agent may sell the Collateral without giving any warranties as
to the Collateral. The Collateral Agent may specifically disclaim or modify any warranties of title or the like. This procedure will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. 

(d) The Collateral Agent shall have no obligation to marshal any of the Collateral. 

9.2 Application of Proceeds. Subject to the provisions of the Credit Agreement, and except as expressly provided elsewhere in this
Agreement, all proceeds received by the Collateral Agent in respect of any sale of, any collection from, or other realization upon all or any part of the Collateral shall be applied in full or in part by the Collateral Agent against, the Secured
Obligations in the following order of priority: first, to the payment of all costs and expenses of such sale, collection or other realization, including reasonable compensation to the Collateral Agent and its agents and counsel, and all other
expenses, liabilities and advances made or incurred by the Collateral Agent in connection therewith, and all amounts for which the Collateral Agent is entitled to indemnification hereunder (in its capacity as the Collateral Agent and not as a
Lender) and all advances made by the Collateral Agent hereunder for the account of the applicable Grantor, and to the payment of all costs and expenses paid or incurred by the Collateral Agent in connection with the exercise of any right or remedy
hereunder or under the Credit Agreement, all in accordance with the terms hereof or thereof; second, to the extent of any excess of such proceeds, to the payment of any Applicable Premium for the ratable benefit of the Lenders; third
to the extent of any excess of such proceeds, to the payment of all other Secured Obligations for the ratable benefit of the Lenders; and fourth, to the extent of any excess of such proceeds, to the payment to or upon the order of the
applicable Grantor or to whosoever may be lawfully entitled to receive the same or as a court of competent jurisdiction may direct. 
 9.3 Sales on Credit. Subject to the provisions of the Credit Agreement, if Collateral Agent sells any of the Collateral upon credit, Grantor will be credited only with payments actually made by
purchaser and received by Collateral Agent and applied to indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, Collateral Agent may resell the Collateral and Grantor shall be credited with proceeds of the sale.

  
 27 

 9.4 Investment Related Property. Subject to the provisions of the Credit Agreement,
each Grantor recognizes that, by reason of certain prohibitions contained in the Securities Act and applicable state securities laws, the Collateral Agent may be compelled, with respect to any sale of all or any part of the Investment Related
Property conducted without prior registration or qualification of such Investment Related Property under the Securities Act and/or such state securities laws, to limit purchasers to those who will agree, among other things, to acquire the Investment
Related Property for their own account, for investment and not with a view to the distribution or resale thereof. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable than those obtainable through a
public sale without such restrictions (including a public offering made pursuant to a registration statement under the Securities Act) and, notwithstanding such circumstances, each Grantor agrees that any such private sale shall be deemed to have
been made in a commercially reasonable manner and that the Collateral Agent shall have no obligation to engage in public sales and no obligation to delay the sale of any Investment Related Property for the period of time necessary to permit the
issuer thereof to register it for a form of public sale requiring registration under the Securities Act or under applicable state securities laws, even if such issuer would, or should, agree to so register it. If the Collateral Agent determines to
exercise its right to sell any or all of the Investment Related Property, upon written request, each Grantor shall and shall cause each issuer of any Pledged Stock to be sold hereunder, each partnership and each limited liability company from time
to time to furnish to the Collateral Agent all such information as the Collateral Agent may request in order to determine the number and nature of interest, shares or other instruments included in the Investment Related Property which may be sold by
the Collateral Agent in exempt transactions under the Securities Act and the rules and regulations of the Securities and Exchange Commission thereunder, as the same are from time to time in effect. 

9.5 Intellectual Property License and NDA and ANDA Escrow Agreement. 

(a) Subject to the provisions of the Credit Agreement, Borrower (individually and on behalf of each of the Grantors) and
the Collateral Agent have entered into the IP License for the purpose of enabling the Collateral Agent, during the continuance of an Event of Default, to exercise rights and remedies under Section 9 hereof at such time, as the Collateral Agent
shall be lawfully entitled to exercise such rights and remedies. 
 (b) Subject to the provisions of the Credit
Agreement, Borrower (individually and on behalf of each other Grantor) and the Collateral Agent have entered into the NDA and ANDA Escrow Agreement for the purpose of enabling the Collateral Agent, during the continuance of an Event of Default, to
exercise rights and remedies under Section 9 hereof at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies. 

  
 28 

 9.6 Intellectual Property. Subject to the provisions of the Credit Agreement:

 (a) Anything contained herein to the contrary notwithstanding, in addition to the other rights and remedies
provided herein, upon the occurrence of and during the continuation of an Event of Default: 
 (i) the Collateral
Agent shall have the right (but not the obligation), upon notice to the applicable Grantor, to bring suit or otherwise commence any action or proceeding in the name of any Grantor, the Collateral Agent or otherwise, in the Collateral Agent’s
sole discretion, to enforce any Intellectual Property rights of such Grantor included in the Collateral, in which event such Grantor shall, at the reasonable request of the Collateral Agent, do any and all lawful acts and execute any and all
documents required by the Collateral Agent in aid of such enforcement, and such Grantor shall promptly, upon demand, reimburse and indemnify the Collateral Agent as provided in Section 12 hereof in connection with the exercise of its rights
under this Section 9.6, and, to the extent that the Collateral Agent shall elect not to bring suit to enforce any Intellectual Property rights as provided in this Section 9.6, each Grantor agrees to use all commercially reasonable
measures, whether by action, suit, proceeding or otherwise, to prevent the infringement, misappropriation, dilution or other violation of any of such Grantor’s rights in the Intellectual Property included in the Collateral by others and for
that purpose agrees to diligently maintain any action, suit or proceeding against any Person so infringing, misappropriating, diluting or otherwise violating as shall be necessary to prevent such infringement, misappropriation, dilution or other
violation; 
 (ii) upon written demand from the Collateral Agent, each Grantor shall grant, assign, convey or
otherwise transfer to the Collateral Agent or such Collateral Agent’s designee all of such Grantor’s right, title and interest in and to any Intellectual Property included in the Collateral and shall execute and deliver to the Collateral
Agent such documents as are necessary or appropriate to carry out the intent and purposes of this Agreement; 

(iii) each Grantor agrees that such an assignment and/or recording shall be applied to reduce the Secured Obligations
outstanding only to the extent that the Collateral Agent (or any other Secured Party) receives cash proceeds in respect of the sale of any such Intellectual Property; 

(iv) within five (5) Business Days after written notice from the Collateral Agent, each Grantor shall make available
to the Collateral Agent, to the extent within such Grantor’s power and authority, such personnel in such Grantor’s employ on the date of such Event of Default as the Collateral Agent may reasonably designate, by name, title or job
responsibility, to permit such Grantor to continue, directly or indirectly, to produce, advertise and sell the products and services sold or delivered by such Grantor under or in connection with any Trademarks or Trademark Licenses, such persons to
be available to perform their prior functions on the Collateral Agent’s behalf and to be compensated by the Collateral Agent at such Grantor’s expense on a per diem, pro-rata basis consistent with the salary and benefit structure
applicable to each as of the date of such Event of Default; and 
 (v) the Collateral Agent shall have the right
to notify, or require each Grantor to notify, any obligors with respect to amounts due or to become due to such Grantor in respect of any Intellectual Property of such Grantor included in the Collateral, of the existence of the security interest
created herein, to direct such obligors to make payment of all such amounts directly to the Collateral Agent, and, upon such notification and at the expense of such Grantor, to enforce collection of any such amounts and to adjust, settle or
compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might have done; 
  

	 	(1)	all amounts and proceeds (including checks and other instruments) received by Grantor in respect of amounts due to such Grantor in respect of the Collateral or any
portion thereof shall be received in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such Grantor and shall be forthwith paid over or delivered to the Collateral Agent in the same form as so received
(with any necessary endorsement) to be held as cash Collateral and applied as provided by Section 9.7 hereof; and 

  
 29 

  

	 	(2)	Grantor shall not adjust, settle or compromise the amount or payment of any such amount or release wholly or partly any obligor with respect thereto or allow any credit
or discount thereon. 

 (b) If (i) an Event of Default shall have occurred and, by reason of
cure, waiver, modification, amendment or otherwise, no longer be continuing, (ii) no other Event of Default shall have occurred and be continuing, (iii) an assignment or other transfer to the Collateral Agent of any rights, title and
interests in and to any Intellectual Property of such Grantor shall have been previously made and shall have become absolute and effective, and (iv) the Secured Obligations shall not have become immediately due and payable, upon the written
request of any Grantor, the Collateral Agent shall promptly execute and deliver to such Grantor, at such Grantor’s sole cost and expense, such assignments or other transfer as may be necessary to reassign to such Grantor any such rights, title
and interests as may have been assigned to the Collateral Agent as aforesaid, subject to any disposition thereof that may have been made by the Collateral Agent; provided, after giving effect to such reassignment, the Collateral Agent’s
security interest granted pursuant hereto, as well as all other rights and remedies of the Collateral Agent granted hereunder, shall continue to be in full force and effect; and provided further, the rights, title and interests so reassigned shall
be free and clear of any other Liens granted by or on behalf of the Collateral Agent and the Secured Parties. 
 9.7 Cash
Proceeds; Deposit Account and Controlled Accounts. Subject to the provisions of the Credit Agreement: (a) If any Event of Default shall have occurred and be continuing, in addition to the rights of the Collateral Agent specified in
Section 6.5 with respect to payments of Receivables, all proceeds of any Collateral received by any Grantor consisting of cash, checks and other near-cash items (collectively, “Cash Proceeds”) shall be held by such Grantor in
trust for the Collateral Agent, segregated from other funds of such Grantor, and shall, forthwith upon receipt by such Grantor, be turned over to the Collateral Agent in the exact form received by such Grantor (duly indorsed by such Grantor to the
Collateral Agent, if required) and held by the Collateral Agent in a Collateral Account. If any Event of Default should have occurred and be continuing, any Cash Proceeds received by the Collateral Agent (whether from a Grantor or otherwise) may, in
the sole discretion of the Collateral Agent, or otherwise at the request of the Requisite Lenders, be applied by the Collateral Agent against the Secured Obligations then due and owing. 

(b) If any Event of Default shall have occurred and be continuing, the Collateral Agent may, in the sole discretion of the Collateral
Agent, or otherwise at the request of the Requisite Lenders, apply the balance from any Deposit Account, Controlled Account or Collateral Account against the Secured Obligations then due and owing. 

(c) Following the application of any proceeds held by the Collateral Agent in accordance with this Section 9.7 and the termination,
cure or waiver of all existing Events of Default in accordance with the terms of the Credit Documents, any excess proceeds then held by the Collateral Agent in accordance with this Section 9.7 shall, at the request of the Borrower, be returned
to the applicable Deposit Account or Controlled Account. 

  
 30 

 SECTION 10. COLLATERAL AGENT. 

The Collateral Agent has been appointed to act as Collateral Agent hereunder by Lenders and, by their acceptance of the benefits hereof,
the other Secured Parties. The Collateral Agent shall be obligated, and shall have the right hereunder, to make demands, to give notices, to exercise or refrain from exercising any rights, and to take or refrain from taking any action (including,
without limitation, the release or substitution of Collateral), solely in accordance with this Agreement and the Credit Agreement. In furtherance of the foregoing provisions of this Section 10, each Secured Party, by its acceptance of the
benefits hereof, agrees that it shall have no right individually to realize upon any of the Collateral hereunder, it being understood and agreed by such Secured Party that all rights and remedies hereunder may be exercised solely by the Collateral
Agent for the benefit of Secured Parties in accordance with the terms of this Section. The provisions of the Credit Agreement relating to the Collateral Agent including, without limitation, the provisions relating to resignation or removal of the
Collateral Agent and the powers and duties and immunities of the Collateral Agent are incorporated herein by this reference and shall survive any termination of the Credit Agreement. 
 SECTION 11. CONTINUING SECURITY INTEREST; TRANSFER OF LOANS. 
 This
Agreement shall create a continuing security interest in the Collateral and shall remain in full force and effect until the payment in full of all Secured Obligations (other than contingent obligations not yet due and payable), be binding upon each
Grantor, its successors and assigns, and inure, together with the rights and remedies of the Collateral Agent hereunder, to the benefit of the Collateral Agent and its successors, transferees and assigns. Without limiting the generality of the
foregoing, but subject to the terms of the Credit Agreement, any Lender may assign or otherwise transfer any Loans held by it to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted
to Lenders herein or otherwise. Upon the payment in full of all Secured Obligations (other than contingent obligations not yet due and payable), the security interest granted hereby shall automatically terminate hereunder and of record and all
rights to the Collateral shall revert to the Grantors. Upon any such termination the Collateral Agent shall, at the Grantors’ expense, execute and deliver to the Grantors or otherwise authorize the filing of such documents as the Grantors shall
reasonably request, including financing statement amendments to evidence such termination. Upon any disposition of property permitted by the Credit Agreement, the Liens granted herein shall be deemed to be automatically released and such property
shall automatically revert to the applicable Grantor with no further action on the part of any Person. The Collateral Agent shall, at the applicable Grantor’s expense, execute and deliver or otherwise authorize the filing of such documents as
such Grantor shall reasonably request, in form and substance reasonably satisfactory to the Collateral Agent, including financing statement amendments to evidence such release. 
 SECTION 12. STANDARD OF CARE; COLLATERAL AGENT MAY PERFORM. 
 The powers
conferred on the Collateral Agent hereunder are solely to protect its interest in the Collateral and shall not impose any duty upon it to exercise any such powers. Except for the exercise of reasonable care in the custody of any Collateral in its
possession and the accounting for moneys actually received by it hereunder, the Collateral Agent shall have no duty as to any Collateral or as to the taking of any necessary steps to preserve rights against prior parties or any other rights
pertaining to any Collateral. The Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation of Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the
Collateral Agent accords its own property. Neither the Collateral Agent nor any of its directors, officers, employees or agents shall be liable for failure to demand, collect or realize upon all or any part of the Collateral or for any delay in
doing so or shall be under any obligation to sell or otherwise dispose of any Collateral upon the request of any Grantor or otherwise. 

  
 31 

 SECTION 13. MISCELLANEOUS. 
 Any notice required or permitted to be given under this Agreement shall be given in accordance with Section 10.1 of the Credit Agreement. No failure or delay on the part of the Collateral Agent in
the exercise of any power, right or privilege hereunder or under any other Credit Document shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein, nor shall any single or partial exercise of
any such power, right or privilege preclude other or further exercise thereof or of any other power, right or privilege. All rights and remedies existing under this Agreement and the other Credit Documents are cumulative to, and not exclusive of,
any rights or remedies otherwise available. In case any provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or
Obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. All covenants hereunder shall be given independent effect so that if a particular action or condition is not permitted
by any of such covenants, the fact that it would be permitted by an exception to, or would otherwise be within the limitations of, another covenant shall not avoid the occurrence of a Default or an Event of Default if such action is taken or
condition exists. This Agreement shall be binding upon and inure to the benefit of the Collateral Agent and the Grantors and their respective successors and permitted assigns. No Grantor shall, without the prior written consent of the Collateral
Agent given in accordance with the Credit Agreement, assign any right, duty or obligation hereunder. This Agreement and the other Credit Documents embody the entire agreement and understanding between the Grantors and the Collateral Agent and
supersede all prior agreements and understandings between such parties relating to the subject matter hereof and thereof. Accordingly, the Credit Documents may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements
of the parties. There are no unwritten oral agreements between the parties. This Agreement may be executed in one or more counterparts (including by telecopy or electronic transmission) and by different parties hereto in separate counterparts, each
of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single
counterpart so that all signature pages are physically attached to the same document. 
 APPLICABLE LAW. THIS AGREEMENT AND
THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THEREOF (OTHER THAN ANY MANDATORY
PROVISIONS OF THE UCC RELATING TO THE LAW GOVERNING PERFECTION AND THE EFFECT OF PERFECTION OF THE SECURITY INTEREST). 

THE PROVISIONS OF THE CREDIT AGREEMENT UNDER THE HEADINGS “CONSENT TO JURISDICTION” AND “WAIVER OF
JURY TRIAL” ARE INCORPORATED HEREIN BY THIS REFERENCE AND SUCH INCORPORATION SHALL SURVIVE ANY TERMINATION OF THE CREDIT AGREEMENT. 
 SECTION 14. CONFLICTS. 
 In the event of any conflict or inconsistency
between the provisions of this Agreement and the Credit Agreement, the provisions of the Credit Agreement shall govern. 

[Remainder of page intentionally left blank] 

  
 32 

 IN WITNESS WHEREOF, each Grantor and the Collateral Agent have caused this Agreement to be
duly executed and delivered by their respective officers thereunto duly authorized as of the date first written above. 
  

			
	K-V Pharmaceutical Company, as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	Zeratech Technologies USA, Inc., as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	DrugTech Corporation, as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	Ethex Corporation, as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	FP1096, Inc., as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:

 [Signature Page to K-V
Pharmaceutical Pledge and Security Agreement] 

  

			
	Nesher Pharmaceuticals Inc., as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	Nesher Solutions USA, Inc., as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	Nesher Discovery Solutions, Inc., as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:
	
	Ther-Rx Corporation, as a Grantor
		
	By:	 	 
		 	Name:
		 	Title:

 [Signature Page to K-V
Pharmaceutical Pledge and Security Agreement] 

  

			
	U.S. HEALTHCARE I, L.L.C., as Collateral Agent
		
	By:	 	 
		 	Authorized Signatory

 [Signature Page
to K-V Pharmaceutical Pledge and Security Agreement]Promissory Note

 Exhibit 4.8 
 TRANCHE B-1 TERM LOAN NOTE 
  

			
	 $40,200,000.00
	  	N-1
		
	 November 17, 2010
	  	New York, New York

 FOR
VALUE RECEIVED, K-V PHARMACEUTICAL COMPANY, a Delaware corporation (“Borrower”), promises to pay U.S. HEALTHCARE I, L.L.C. (“Payee”) or its registered assigns the principal amount of forty million two
hundred thousand dollars ($40,200,000.00) in the installments referred to below. 
 Borrower also promises to pay interest on
the unpaid principal amount hereof, from the date hereof until paid in full, at the rates and at the times which shall be determined in accordance with the provisions of that certain Credit and Guaranty Agreement, dated as of November 17, 2010
(as it may be amended, supplemented or otherwise modified, the “Credit Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined), by and among Borrower, certain Subsidiaries of the
Borrower, as Guarantors, the Lenders party thereto from time to time, and U.S. HEALTHCARE I, L.L.C. (“U.S. Healthcare”), as Administrative Agent and Collateral Agent. 

Borrower shall make scheduled principal payments on this Note as set forth in Section 2.9 of the Credit Agreement. 

This Note is one of the “Tranche B-1 Term Loan Notes” in the aggregate principal amount of $60,000,000 and is issued pursuant
to and entitled to the benefits of the Credit Agreement, to which reference is hereby made for a more complete statement of the terms and conditions under which the Tranche B-1 Term Loan evidenced hereby was made and is to be repaid. 

All payments of principal and interest in respect of this Note shall be made in lawful money of the United States of America in same day
funds at the Principal Office of the Administrative Agent or at such other place as shall be designated in writing for such purpose in accordance with the terms of the Credit Agreement. Unless and until an Assignment Agreement effecting the
assignment or transfer of the obligations evidenced hereby shall have been accepted by the Administrative Agent and recorded in the Register, Borrower, each Agent and Lenders shall be entitled to deem and treat Payee as the owner and holder of this
Note and the obligations evidenced hereby. Payee hereby agrees, by its acceptance hereof, that before disposing of this Note or any part hereof it will make a notation hereon of all principal payments previously made hereunder and of the date to
which interest hereon has been paid; provided, that the failure to make a notation of any payment made on this Note shall not limit or otherwise affect the obligations of Borrower hereunder with respect to payments of principal of or interest on
this Note. 
 This Note is subject to mandatory prepayment and to prepayment at the option of Borrower, each as provided in the
Credit Agreement. 

 THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT FOR PURPOSES OF SECTIONS 1271, 1272,
1273 AND 1275 OF THE UNITED STATES INTERNAL REVENUE CODE OF 1986, AS AMENDED. THOMAS S. MCHUGH (WITH AN ADDRESS AT C/O K-V PHARMACEUTICAL COMPANY, ONE CORPORATE WOODS DRIVE, BRIDGETON, MO 63044) WILL PROMPTLY MAKE AVAILABLE TO HOLDERS UPON REQUEST,
THE ISSUE PRICE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT, THE ISSUE DATE AND THE YIELD TO MATURITY OF THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF BORROWER AND PAYEE HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE
WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF. 
 THIS NOTE AND THE
RIGHTS AND OBLIGATIONS OF BORROWER AND PAYEE HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF. 

IN THE EVENT OF A CONFLICT BETWEEN THIS NOTE AND THE CREDIT AGREEMENT, THE PROVISIONS OF THE CREDIT AGREEMENT WILL GOVERN. 

Upon the occurrence of an Event of Default, the unpaid balance of the principal amount of this Note, together with all accrued and unpaid
interest thereon, may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Credit Agreement. 
 The terms of this Note are subject to amendment only in the manner provided in the Credit Agreement. 
 No reference herein to the Credit Agreement and no provision of this Note or the Credit Agreement shall alter or impair the obligations of Borrower, which are absolute and unconditional, to pay the
principal of and interest on this Note at the place, at the respective times, and in the currency herein prescribed. 
 Borrower
promises to pay all costs and expenses, including reasonable attorneys’ fees, all as provided in the Credit Agreement, incurred in the collection and enforcement of this Note. Borrower and any endorsers of this Note hereby consent to renewals
and extensions of time at or after the maturity hereof, without notice, and hereby waive diligence, presentment, protest, demand notice of every kind and, to the full extent permitted by law, the right to plead any statute of limitations as a
defense to any demand hereunder. 
 [Signature page follows] 

  
 2 

 IN WITNESS WHEREOF, Borrower has caused this Note to be duly executed and delivered by its officer
thereunto duly authorized as of the date and at the place first written above. 
  

	
	K-V PHARMACEUTICAL COMPANY
	
	  
	 Name:

Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]